How much weight are people losing on Wegovy?

The biggest myth: everyone loses the same amount

Scroll through social media and you will find striking numbers attached to Wegovy, twenty pounds in a month, thirty percent of body weight, dramatic before-and-afters. The reality in published research is more nuanced. The STEP 1 trial found an average reduction of approximately 15% of body weight at 68 weeks among participants taking semaglutide 2.4mg. That is a genuinely significant result. But averages conceal a wide spread: some participants lost considerably more, others considerably less, and a meaningful proportion stopped treatment early because of side effects or for other reasons.

Average figures also assume the full escalating dose schedule is completed and maintained. The titration pathway for Wegovy starts well below the 2.4mg maintenance dose, and the early weeks of treatment tend to produce slower loss while the body adjusts. Expecting dramatic results by week four sets people up for disappointment. If you want a fuller picture of how much weight people actually lose on Wegovy and what the evidence actually says week by week, our breakdown of Wegovy weight-loss results walks through the trial data in more detail.

The NHS semaglutide medicines page is candid about this variability too: results depend on how well the medicine is tolerated, the lifestyle changes made alongside it, and whether treatment continues long enough to reach the maintenance phase. None of this makes Wegovy ineffective, it makes realistic expectations the starting point for success.

What the pricing picture actually looks like in the UK

Wegovy is not available on the NHS to most people right now. The NICE appraisal (TA875) restricts NHS access to specialist weight management services with multidisciplinary support, for a maximum of two years. Waiting lists at those services are long in most areas. For most people who want to start treatment, private prescription is the practical route.

Private Wegovy pricing in the UK varies meaningfully between providers. Headline prices you see advertised do not always tell the full story. A quoted monthly figure sometimes excludes the initial consultation fee, the prescription charge, delivery costs, or access to clinical support if you have a question mid-treatment. When you add those components back in, the gap between providers closes, and the cheapest headline price may not be the cheapest total cost. Our Wegovy pricing page sets out what private treatment typically costs and what different providers include, without naming competitors.

It is also worth knowing that pricing has shifted. Eli Lilly's UK list price increase for Mounjaro in September 2025 drew attention to how quickly the private GLP-1 market can move; Wegovy pricing has followed a similar pattern of provider variation. The context around Wegovy price changes is worth reading if cost is a central concern for you.

What the price you pay at nume covers

We are not the cheapest provider. That is a deliberate choice, not an oversight. The single price you pay at nume includes your consultation, the prescription itself, the medicine, and 7-day-a-week priority aftercare from our clinical team, there is no subscription, no auto-renewal, and nothing charged separately on top. Every repeat order is clinically re-reviewed by a GPhC-registered Independent Prescriber before it is dispensed. Your current treatment pricing is shown on our treatment page.

What arrives at your door reflects that standard. Your Wegovy is dispatched from our GPhC-registered pharmacy in plain unbranded packaging via DPD; you get a tracking link and can follow the pen to your address. The pen itself is a pre-filled Novo Nordisk device that leaves the licensed UK supply chain and goes nowhere else before it reaches you. That provenance matters, and we will explain why in the next section.

If you want to understand the full scope of what our clinical team reviews before approving treatment, our about page covers the identity verification, live weight check, GP notification and evidence review that happen before any prescription is issued. Our lead prescriber's profile is there too, if you want to know who is actually reviewing your consultation.

Why price is the wrong thing to optimise for a prescription medicine

The MHRA has been clear: Wegovy is a prescription-only medicine, not assessed for quick or cosmetic weight loss. Selling it without a valid prescription is illegal. Yet the counterfeit market for weight-loss injections in the UK is large and actively harmful, fake pens seized in recent enforcement operations have been found to contain insulin, and the MHRA has documented hospitalisations as a result. The MHRA's Yellow Card scheme exists partly so patients can report suspect sellers and products.

The practical red flags are worth knowing: any seller offering semaglutide without a clinical assessment, social media accounts promoting these medicines, prices significantly below the market range, and discount codes from unverified sources should all give you pause. If you are trying to work out how much weight people have actually lost on Wegovy and whether the results justify the cost, the evidence is more useful than promotional claims. nume does not run discount codes, promotional offers or voucher schemes for prescription medicines. We never will. A small price difference is not worth the risk of receiving a product with no guarantee of what is actually in it.

The right question to ask of any provider is not whether their price is the lowest, but whether they are on the GPhC pharmacy register, whether a real prescriber reviews your consultation, and whether the medicine travels through the licensed UK supply chain. Those are the checks that protect you. Understanding how much weight you should be losing on Wegovy at each stage of treatment is also part of using it safely, because unrealistic expectations can push people toward unverified sources when results feel slower than they hoped. If you want to explore treatment through a provider that takes them seriously, start your free consultation here.